Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-14
1987-09-01
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514222, 514229, 514231, 514234, 514253, 514291, 540597, 544 584, 544125, 544126, 544357, 544361, 544405, 546 62, 546 80, 546 89, 546 92, A61K 31445, C07D491147, C07D49514
Patent
active
046909281
ABSTRACT:
Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective .alpha..sub.6 -adrenergic receptor antagonists and thereby useful as antidepressants, antihypertensives, antidiabetics, antiobesity and platelet aggregation inhibitors.
REFERENCES:
Burger's Medicinal Chemistry, 4th ed. Pt. III, pp. 307-310.
Opalko et al., Chem. Abst. 96:162676j (1982).
Kluze et al., Chem. Abstr. 91:204200d (1979).
Baldwin John J.
Huff Joel R.
Vacca Joseph P.
Merck & Co. , Inc.
Nicholson William H.
Schwartz Richard A.
Sudol Michael C.
LandOfFree
Substituted hexahydro arylquinolizines as .alpha..sub.2 blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted hexahydro arylquinolizines as .alpha..sub.2 blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hexahydro arylquinolizines as .alpha..sub.2 blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265089